HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 136 filers reported holding HORIZON PHARMA PLC in Q4 2014. The put-call ratio across all filers is 0.21 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $13,889,000 | -17.9% | 525,500 | -39.3% | 0.09% | -24.6% |
| Q4 2018 | $16,922,000 | +162.5% | 866,023 | +163.0% | 0.12% | +320.7% |
| Q3 2018 | $6,447,000 | +464.5% | 329,253 | +377.6% | 0.03% | +480.0% |
| Q2 2018 | $1,142,000 | -57.7% | 68,940 | -63.8% | 0.01% | -54.5% |
| Q1 2018 | $2,701,000 | -83.6% | 190,218 | -83.1% | 0.01% | -78.4% |
| Q4 2017 | $16,432,000 | +1305.6% | 1,125,513 | +1120.7% | 0.05% | +920.0% |
| Q3 2017 | $1,169,000 | -91.6% | 92,200 | -92.2% | 0.01% | -91.4% |
| Q2 2017 | $13,958,000 | +2777.9% | 1,175,939 | +3821.9% | 0.06% | +1833.3% |
| Q4 2016 | $485,000 | -94.5% | 29,984 | -94.4% | 0.00% | -94.7% |
| Q2 2016 | $8,806,000 | +5204.8% | 534,640 | +5230.4% | 0.06% | +5600.0% |
| Q1 2016 | $166,000 | -96.8% | 10,030 | -95.0% | 0.00% | -97.6% |
| Q1 2015 | $5,194,000 | +8.9% | 200,000 | -45.9% | 0.04% | -4.5% |
| Q4 2014 | $4,769,000 | – | 370,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scale Management, LLC | 1,710,451 | $37,065,000 | 56.74% |
| Broadfin Capital, LLC | 8,131,310 | $176,205,000 | 10.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,684,801 | $253,210,000 | 10.26% |
| ATERNALIS CAPITAL LLC | 410,000 | $8,885,000 | 5.84% |
| JW Asset Management, LLC | 673,075 | $14,586,000 | 5.44% |
| NEXTHERA CAPITAL LP | 144,000 | $3,120,000 | 4.43% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 739,485 | $16,025,000 | 2.77% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,519,955 | $54,607,000 | 2.66% |
| Ratan Capital Management LP | 500,000 | $10,835,000 | 2.39% |
| TIGER MANAGEMENT L.L.C. | 823,577 | $17,847,000 | 2.30% |